Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

BACKGROUND: Controversy exists as to whether low-dose aspirin use may give benefit in primary prevention of cardiovascular (CV) events. We hypothesized that the benefits of aspirin are underevaluated. METHODS: We investigated 12,123 Caucasian patients presenting to hospital with acute coronary syndr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bugiardini, Raffaele, Pavasović, Saša, Yoon, Jinsung, van der Schaar, Mihaela, Kedev, Sasko, Vavlukis, Marija, Vasiljevic, Zorana, Bergami, Maria, Miličić, Davor, Manfrini, Olivia, Cenko, Edina, Badimon, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599315/
https://www.ncbi.nlm.nih.gov/pubmed/33150322
http://dx.doi.org/10.1016/j.eclinm.2020.100548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599315/
https://www.ncbi.nlm.nih.gov/pubmed/33150322
http://dx.doi.org/10.1016/j.eclinm.2020.100548

Ejemplares similares